| Hikal Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524735 |
NSE Symbol : HIKAL |
P/E(TTM) : 292.05 |
|
ISIN Demat : INE475B01022 |
Div & Yield% : 0.33 |
EPS(TTM) : 0.83 |
|
Book Value(₹) : 96.84 |
Market Cap(₹Cr) : 2,988.81 |
Face Value(₹) : 2.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 316.20 | 371.30 | 550.00 | 438.90 | 450.80 | 403.80 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 316.20 | 371.30 | 550.00 | 438.90 | 450.80 | 403.80 |
| Other Operating Income | 2.30 | 9.10 | 2.40 | 8.80 | 2.10 | 3.00 |
| Other Income | 1.90 | 1.00 | 0.50 | 3.60 | 0.40 | 0.50 |
| Total Income | 320.40 | 381.40 | 552.90 | 451.30 | 453.30 | 407.30 |
| Total Expenditure | 311.10 | 355.60 | 428.90 | 375.50 | 378.20 | 348.70 |
| PBIDT | 9.30 | 25.80 | 124.00 | 75.80 | 75.10 | 58.60 |
| Interest | 14.90 | 17.10 | 17.90 | 18.70 | 18.80 | 19.80 |
| PBDT | -5.60 | 8.70 | 106.10 | 57.10 | 56.30 | 38.80 |
| Depreciation | 41.20 | 39.40 | 37.70 | 33.20 | 31.70 | 31.80 |
| Tax | 0.00 | 0.00 | 17.30 | 4.50 | 6.70 | 1.50 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -12.10 | -8.00 | 0.80 | 2.10 | -0.20 | 0.30 |
| Reported Profit After Tax | -34.70 | -22.70 | 50.30 | 17.30 | 18.10 | 5.20 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -34.70 | -22.70 | 50.30 | 17.30 | 18.10 | 5.20 |
| EPS (Unit Curr.) | -2.81 | -1.84 | 4.08 | 1.40 | 1.47 | 0.42 |
| EPS (Adj) (Unit Curr.) | -2.81 | -1.84 | 4.08 | 1.40 | 1.47 | 0.42 |
| Calculated EPS (Unit Curr.) | -2.81 | -1.84 | 4.07 | 1.40 | 1.47 | 0.42 |
| Calculated EPS (Adj) (Unit Curr.) | -2.81 | -1.84 | 4.07 | 1.40 | 1.47 | 0.42 |
| Calculated EPS (Ann.) (Unit Curr.) | -11.24 | -7.35 | 16.29 | 5.60 | 5.86 | 1.68 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -11.24 | -7.35 | 16.29 | 5.60 | 5.86 | 1.68 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 30.00 | 0.00 | 0.00 |
| Equity | 24.70 | 24.70 | 24.70 | 24.70 | 24.70 | 24.70 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 2.94 | 6.95 | 22.55 | 17.27 | 16.66 | 14.51 |
| PBDTM(%) | -1.77 | 2.34 | 19.29 | 13.01 | 12.49 | 9.61 |
| PATM(%) | -10.97 | -6.11 | 9.15 | 3.94 | 4.02 | 1.29 |